For the first time, scientists have engineered the complex biological process of translation into a designer organelle in a living mammalian cell. Research by the Lemke group at the European Molecular Biology Laboratory (EMBL) – in collaboration with JGU Mainz and IMB Mainz – used this technique to create a membraneless organelle that can build proteins from natural and synthetic amino acids carrying new functionality. Their results – published in Science on 29 March – allow scientists to study, tailor, and control cellular function in more detail.
During evolution, the development of new organelles allows cells and organisms to become more complex, due to the ability to sort cellular processes into specific hotspots. “Our tool can be used to engineer translation, but potentially also other cellular processes like transcription and post-translational modifications. This might even allow us to engineer new types of organelles that extend the functional repertoire of natural complex living systems,” explains Christopher Reinkemeier, PhD student at EMBL and JGU Mainz and co-first author of the paper. “We could for example incorporate fluorescent building blocks that allow a glimpse inside the cell using imaging methods.”
“The organelle can make proteins by using synthetic non-canonical amino acids. Currently we know of more than 300 different non-canonical amino acids – compared to 20 which are naturally occurring. We are no longer restricted to the latter ones,” says co-first author Gemma Estrada Girona. “The novelty we introduce is the ability to use these in a confined space, the organelle, which minimises the effects on the host.”
About EMBL
EMBL is Europe’s flagship laboratory for the life sciences. Established in 1974 as an intergovernmental organisation, EMBL is supported by over 20 member states. EMBL performs fundamental research in molecular biology, studying the story of life. The institute offers services to the scientific community; trains the next generation of scientists and strives to integrate the life sciences across Europe. EMBL is international, innovative and interdisciplinary. Its more than 1700 staff, from over 80 countries, operate across six sites in Barcelona (Spain), Grenoble (France), Hamburg (Germany), Heidelberg (Germany), Hinxton (UK) and Rome (Italy). EMBL scientists work in independent groups and conduct research and offer services in all areas of molecular biology. EMBL research drives the development of new technology and methods in the life sciences. The institute works to transfer this knowledge for the benefit of society.